Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
about
Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched dietIdentification of distant drug off-targets by direct superposition of binding pocket surfacesProtective effects of gingerol on streptozotocin-induced sporadic Alzheimer's disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta - secretases and APH1aA comparative study of neuroprotective effect of angiotensin converting enzyme inhibitors against scopolamine-induced memory impairments in rats.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Renin-angiotensin system in pain: existing in a double life?Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia.Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats.Telmisartan ameliorates carbon tetrachloride-induced acute hepatotoxicity in rats.Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia.Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress.Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.Neuromodulatory Effect of Thymoquinone in Attenuating Glutamate-Mediated Neurotoxicity Targeting the Amyloidogenic and Apoptotic Pathways.
P2860
Q28535014-5C884D81-DA65-4EAE-8CE0-79039F81A000Q28538129-47EED601-CD44-42FD-9812-06EA2E8F3AE7Q33767277-6371F35C-2B4C-4F1C-8FD9-18C166CC12DFQ35973725-1A15011D-80AA-425D-B66E-81EA2FEEDEDFQ38286222-BB5F4524-F1F6-4728-805A-A53F6B202A72Q38287403-61774EF1-E7AD-4B14-B88B-40CFB91B72BAQ38571878-9FFFAB18-2FB2-4FD5-A478-1A53107567C3Q41197143-923AFABB-3FFD-4CAE-84D1-D69335063A06Q41860101-67B2D901-7274-4AA3-BE33-D46D66CA6A21Q42699305-9AB4DD01-B65D-4568-868B-447709ED270AQ46495521-E60437A0-27EF-46CF-B05E-C463BE25BB5CQ46889317-CC730649-C3C8-49DB-8F1A-958CFFC1878EQ50679658-679FF651-51F8-4EAD-A6FC-B6F4766E60E5Q50693406-DE7CFB06-1BA4-4851-B245-4A43B1969F9FQ55429129-9E9FEEC3-FD65-466F-89AC-8B6D18174D4C
P2860
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@en
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@nl
type
label
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@en
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@nl
prefLabel
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@en
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@nl
P2093
P2860
P356
P1476
Attenuating effect of lisinopr ...... of PPAR-γ agonistic property.
@en
P2093
Amteshwar S Jaggi
Birdavinder Singh
Nirmal Singh
P2860
P304
P356
10.1177/1470320312459977
P577
2012-10-11T00:00:00Z